71 West Capital Partners

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 2111530 BOSTON, MA

Position in REGN

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$321,746

+$63,685 QoQ

Shares Held

516

+54.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#922

of 1,322 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

71 West Capital Partners holds $3,182,250 across 4 Biotechnology names. REGN ranks #4 (10.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	43,164	$1,527,573
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,892	$939,813
3	VRDN	Viridian Therapeutics, Inc.\DE	21,400	$393,118
4	REGN	Regeneron Pharmaceuticals, Inc. This page	516	$321,746

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$321,746	516	+54.5%	Shares	Sole	2026-08-04
2026-03-31	$258,061	334	+11.3%	Shares	Sole	2026-05-06
2025-12-31	$231,561	300	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.